Hillsdale Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Sell
20,530
-89,520
-81% -$6.1M 0.04% 328
2026
Q1
$7.11M Buy
110,050
+2,600
+2% +$183K 0.19% 117
2025
Q4
$7.23M Buy
107,450
+13,450
+14% +$905K 0.2% 121
2025
Q3
$6.89M Sell
94,000
-400
-0.4% -$26.6K 0.21% 129
2025
Q2
$4.91M Sell
94,400
-3,600
-4% -$205K 0.18% 171
2025
Q1
$6.25M Sell
98,000
-8,200
-8% -$476K 0.32% 48
2024
Q4
$5.08M Buy
106,200
+100
+0.1% +$5.13K 0.26% 77
2024
Q3
$6.07M Sell
106,100
-2,300
-2% -$132K 0.47% 47
2024
Q2
$5.68M Sell
108,400
-4,500
-4% -$197K 0.45% 50
2024
Q1
$4.59M Buy
+112,900
New +$4.23M 0.36% 89
2021
Q2
– Sell
-77,800
Closed -$3.24M – 605
2021
Q1
$3.24M Buy
77,800
+800
+1% +$36.5K 0.27% 131
2020
Q4
$3.29M Buy
+77,000
New +$2.77M 0.31% 114
2020
Q1
– Sell
-43,300
Closed -$768K – 627
2019
Q4
$768K Sell
43,300
-6,000
-12% -$104K 0.07% 278
2019
Q3
$765K Buy
+49,300
New +$812K 0.07% 265

Other funds holding HALO

Hillsdale Investment Management's HALO Position: Q2 2026 in Review

Hillsdale Investment Management reduced its Halozyme (HALO) stake by 81% in Q2 2026, selling an estimated $6.1M and leaving 20,530 shares worth $1.61M. The position accounts for 0.04% of the portfolio, ranked #328.

Hillsdale Investment Management first reported a position in HALO in Q3 2019 and has held it in 14 quarters since. The position peaked at $7.23M in Q4 2025. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Hillsdale Investment Management held 20,530 shares of Halozyme worth $1.61M as of Q2 2026.
  • Hillsdale Investment Management sold 89,520 Halozyme shares in Q2 2026, an estimated $6.1M.
  • Halozyme made up 0.04% of Hillsdale Investment Management's portfolio in Q2 2026, its #328 holding.
  • Hillsdale Investment Management first reported a position in Halozyme in Q3 2019 and has held it in 14 quarters since.
  • Hillsdale Investment Management's Halozyme position peaked at $7.23M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.